Frontlight ResearchEarly access
Trial site
Diabetes & Glandular Disease Clinic, P.A.
- 5running trials
- 7closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes9 trials
- Type 1 diabetes4 trials
- Obesity3 trials
- Cushing's syndrome1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Phase
- Phase 25 trials
- Phase 35 trials
- Phase 1/21 trial
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Biomea Fusion Inc.3 trials
- Boehringer Ingelheim2 trials
- Ionis Pharmaceuticals, Inc.2 trials
- Carmot Therapeutics, Inc.1 trial
- Endogenex, Inc.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes2 recruiting
- Cushing's syndrome1 recruiting
Closed trials
Completed
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Completed
Completed
Completed
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Completed
Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026